PNT

POINT Biopharma Global Inc. Common Stock
PNT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

18 hedge funds and large institutions have $186M invested in POINT Biopharma Global Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$21.6M
2
+$21.6M
3
+$21.6M
4
ACA
Avoro Capital Advisors
New York
+$14.4M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$14.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$21.6M
2
$21.6M
3
$21.6M
4
$14.4M
5
$14.4M
6
$14.4M
7
$14.4M
8
$13.3M
9
$13.1M
10
$7.2M
11
$7.19M
12
$7.19M
13
$7.05M
14
$5.03M
15
$1.79M
16
$708K
17
$680K
18
$288K